BP000443-HIV-134: Recombinant HIV-2 gp32
Source: E. coli-derived.
Specificity: Immunoreactive with all sera of HIV-2 infected individuals.
Purity > 95%, by SDS-PAGE.
Applications: WB, ELISA.BP000443-HIV-135: Recombinant HIV-2 gp32, Biotin Labeled
Source: E. coli-derived.
Specificity: Immunoreactive with all sera of HIV-2 infected individuals.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000443-HIV-137: Recombinant HIV-2 gp32, HRP Labeled
Source: E. coli-derived.
Specificity: Immunoreactive with all sera of HIV-2 infected individuals.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000444-HIV-138: Recombinant HIV-2 gp36
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000444-HIV-139: Recombinant HIV-2 gp36 (390-702 a.a.)
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000444-HIV-151: Recombinant HIV-2 gp36, MBP Tag
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000444-HIV-152: Recombinant HIV-2 gp36, His Tag
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISABP000456-MAL-001: Recombinant Plasmodium Falciparum HSP70
Source: E. coli-derived.
Purity > 95%, by 10% HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000496-PRO-560: Human Hemopexin (HPX) Protein
Source: Human Plasma-derived.
Purity: > 95%.BP000605-ENZ-412: Recombinant Human FKBP4
Source: E. coli-derived.
Specific activity is > 300 nmoles/min/mg, and is defined as the amount of enzyme that cleaves 1umole of suc-AAFP-pNA per minute at 25C in Tris-Hcl pH 8.0 using chymotrypsin.
Purity > 90%, by SDS-PAGE.